Cleared Traditional

K831809 - FOGARTY OCCLUDER PAD

K831809 is an FDA 510(k) clearance for FOGARTY OCCLUDER PAD, manufactured by Thomas J. Fogarty, M.D.. The device is a Class 2 Cardiovascular device with product code DXC cleared through the Traditional 510(k) pathway after a 448-day FDA review.

K831809 · Thomas J. Fogarty, M.D. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1984
Decision
448d
Days
Class 2
Risk

K831809 is an FDA 510(k) clearance for the FOGARTY OCCLUDER PAD. Classified as Clamp, Vascular (product code DXC), Class II - Special Controls.

Submitted by Thomas J. Fogarty, M.D. (Walker, US). The FDA issued a Cleared decision on August 27, 1984 after a review of 448 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.4450 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Cardiovascular submissions.

View all Thomas J. Fogarty, M.D. devices

FDA 510(k) Submission Details - K831809

510(k) Number K831809 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 06, 1983
Decision Date August 27, 1984
Days to Decision 448 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
323d slower than avg
Panel avg: 125d · This submission: 448d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DXC Device Classification - Class 2, Special Controls

Product Code DXC Clamp, Vascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.4450
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXC Clamp, Vascular

All 169
Devices cleared under the same product code (DXC) and FDA review panel - the closest regulatory comparables to K831809.
VASCULAR CLAMP
K881158 · T. Korossurgical Instruments Corp. · Jun 1988
AUTO SUTURE DISPOSABLE APPROXIMATING CLAMP*
K875090 · United States Surgical, A Division of Tyco Healthc · Feb 1988
MICRO ANASTOMOSIS CLAMP
K861924 · Pilling Co. · Jun 1986
FOGARTY 6MM SOFTJAW CLIP
K832554 · American Edwards Laboratories · Sep 1983
P-S BERLIN VESSEL CLAMP
K820949 · Pudenz-Schulte Medical Research Corp. · Apr 1982
VASCULAR PAWS
K813062 · Sil-Med Corp. · Dec 1981